Author:
Talbot Peter S,Bradley Stefan,Clarke Cyril P,Babalola Kola O,Philipp Andrew W,Brown Gavin,McMahon Adam W,Matthews Julian C
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference57 articles.
1. Arterburn DE, Crane PK, Veenstra DL (2004). The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 164: 994–1003.
2. Babalola KO, Cootes TF, Twining CJ, Petrovic V, Taylor CJ (2008). 3D brain segmentation using active appearance models and local regressors. Proceedings of the 11th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI), Lecture Notes in Computer Science 5241: 401–408.
3. Bae SK, Cao S, Seo K-A, Kim H, Kim M-J, Shon J-H et al (2008). Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. Drug Metab Dispos 36: 1679–1688.
4. Baxter K (ed). (2007). Stockley's Drug Interactions, 8th Revised edn. Pharmaceutical Press: London, UK.
5. BNF (2009). Joint Formulary Committee. British National Formulary, 57th edn. British Medical Association and Royal Pharmaceutical Society of Great Britain: London.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献